Article
Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact.
American journal of hematology - 1 Dec 2021
Krzisch Daphné, Guedes Nayara, Boccon-Gibod Clémentine, Baron Marine, Bravetti Clotilde, Davi Frédéric, Armand Marine, Smagghe Luce, Caron Jonathan, Bernard Olivier A, Susin Santos, Chapiro Elise, Leblond Véronique, Nguyen-Khac Florence, Roos-Weil Damien
Abstract excerpt
While Waldenström macroglobulinemia (WM) is characterized by an almost unifying mutation in MYD88, clinical presentation at diagnosis and response to therapy can be widely different among WM patients. Current prognostic tools only partially address this clinical heterogeneity. Limited data compiling both molecular and cytogenetic information have been used in risk prognostication in WM. To investigate the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.